Data / Drug companies / Zoetis Inc.
Zoetis Inc.: 29 products in the FDA NDC directory, labeler code 54771
Updated November 6, 2026. Source: US Food and Drug Administration, National Drug Code Directory (openFDA).
Zoetis Inc. (labeler code 54771) lists 29 products in the FDA National Drug Code Directory. By type: 24 drugs for further processing, 5 bulk ingredients. Its main marketing category is drugs for further processing. The newest product started marketing on May 1, 2026.
The request: Watch Zoetis Inc. (FDA labeler code 54771): each new product listing and each discontinued product. $10 of work on sign-up, no card.
SpecStream is the live web data engine for teams and agents. It reads the National Drug Code Directory that FDA publishes, and this page is that reading. Ask for the companies that make a drug, a class or a dosage form, with their headquarters, website and size added from the web, and new listings and discontinued products arrive in your sheet, CRM, Slack or agent as FDA posts them.
- Labeler code
- 54771
- Products in commercial distribution
- 29
- Packages
- 33
- Finished drugs by generic name
- 0
- Prescription products
- 0
- Over the counter products
- 0
- Started marketing in the last 12 months
- 1
- Earliest marketing start
- February 24, 2016
- openFDA record search
- api.fda.gov
Products by marketing category
Share of the company's products in commercial distribution.
| Marketing category | Products | Share |
|---|---|---|
| Drugs for further processing | 19 | 65.5% |
| Bulk ingredients | 5 | 17.2% |
| Export only | 5 | 17.2% |
Products by type
| Type | Products | Share |
|---|---|---|
| Drugs for further processing | 24 | 82.8% |
| Bulk ingredients | 5 | 17.2% |
Dosage forms
| Dosage form | Products | Share |
|---|---|---|
| Tablet, chewable | 15 | 51.7% |
| Powder | 4 | 13.8% |
| Tablet, coated | 3 | 10.3% |
| Tablet | 3 | 10.3% |
| Solution | 2 | 6.9% |
| Liquid | 1 | 3.4% |
| Paste | 1 | 3.4% |
Newest products
By marketing start date.
| Product | Product NDC | Dosage form | Marketing category | Marketing start |
|---|---|---|---|---|
| Malic acid, benzoic acid, salicylic acid | 54771-7600 | Solution | Drugs for further processing | May 1, 2026 |
| Vitamins | 54771-8443 | Liquid | Export only | January 31, 2025 |
| Nutritional supplement | 54771-8451 | Tablet | Export only | December 17, 2024 |
| Nutritional supplement | 54771-8448 | Tablet | Export only | December 17, 2024 |
| Nutritional supplement | 54771-8446 | Tablet | Export only | December 17, 2024 |
| Doxycycline | 54771-5246 | Paste | Export only | November 1, 2023 |
| Oclacitinib maleate | 54771-1209 | Tablet, chewable | Drugs for further processing | June 26, 2023 |
| Oclacitinib maleate | 54771-1208 | Tablet, chewable | Drugs for further processing | June 26, 2023 |
| Oclacitinib maleate | 54771-1207 | Tablet, chewable | Drugs for further processing | June 26, 2023 |
| Sarolaner | 54771-2716 | Powder | Bulk ingredients | August 20, 2021 |
| Moxidectin | 54771-7016 | Powder | Bulk ingredients | August 11, 2021 |
| Doramectin | 54771-0207 | Powder | Bulk ingredients | March 1, 2021 |
| Oclacitinib maleate | 54771-0497 | Tablet, coated | Drugs for further processing | July 24, 2020 |
| Oclacitinib maleate | 54771-0496 | Tablet, coated | Drugs for further processing | July 24, 2020 |
| Oclacitinib maleate | 54771-0495 | Tablet, coated | Drugs for further processing | July 24, 2020 |
| Oclacitinib maleate | 54771-1344 | Powder | Bulk ingredients | March 25, 2020 |
| Sarolaner, moxidectin, and pyrantel | 54771-2684 | Tablet, chewable | Drugs for further processing | February 19, 2020 |
| Sarolaner, moxidectin, and pyrantel | 54771-2671 | Tablet, chewable | Drugs for further processing | February 19, 2020 |
| Sarolaner, moxidectin, and pyrantel | 54771-2670 | Tablet, chewable | Drugs for further processing | February 19, 2020 |
| Sarolaner, moxidectin, and pyrantel | 54771-2669 | Tablet, chewable | Drugs for further processing | February 19, 2020 |
| Sarolaner, moxidectin, and pyrantel | 54771-2668 | Tablet, chewable | Drugs for further processing | February 19, 2020 |
| Sarolaner, moxidectin, and pyrantel | 54771-2667 | Tablet, chewable | Drugs for further processing | February 19, 2020 |
| Bedinvetmab | 54771-2782 | Solution | Bulk ingredients | January 23, 2020 |
| Sarolaner | 54771-1376 | Tablet, chewable | Drugs for further processing | February 24, 2016 |
| Sarolaner | 54771-1375 | Tablet, chewable | Drugs for further processing | February 24, 2016 |
CC0 1.0 public domain dedication (openFDA). Counts are products in the FDA National Drug Code Directory on November 6, 2026: 138,262 products in commercial distribution, meaning without a marketing end date in the past. A company is a labeler code; one company can hold several codes, and the directory carries no address. Inclusion in the directory is not FDA approval, and the marketing category says under which kind of application or rule a product is sold. This page uses openFDA data and is not endorsed or certified by FDA. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.